Exiqon

Exiqon Announces 2009 North American Grant Award Winners

... exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today...nners of their 2009 North American Grant Program. exiqon had recently announced the development of a new re... (PRWEB) July 1, 2009 -- exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today...

Exiqon Announces New Grant Program for MicroRNA Research

... exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today... (PRWEB) May 15, 2009 -- exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today...quot; says Erik Holmlin, Chief Commercial Officer, exiqon A/S. The ...

Exiqon in Medical Technology

Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center

... Summary: exiqon A/S Today Announces That it has Entered Into a Co...VEDBAEK, Denmark, May 27 /PRNewswire-FirstCall/ -- exiqon A/S, a leading supplier of high-value gene express...markers for breast cancer. Under this agreement, exiqon will use its miRCURY(TM) LNA(TM) products to disco...

Exiqon in Biological Technology

Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S

THOROLD, ON, March 17 /PRNewswire/ - Norgen Biotek, an innovative Canadian biotechnology company focusing primarily on advancing powerful tools for nucleic acids and protein purification, today announced the signing of an OEM agreement with Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") to supply RNA p...

Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.

COPENHAGEN, October 16 /PRNewswire-FirstCall/ -- Exiqon today announces the adoption of the name Exiqon Diagnostics for its U.S. subsidiary to signal the company's commitment to expanding its business to a broad offering in molecular and cellular-based diagnostics that guide treatment decision...

Report Regarding the Managements' and Closely Related Parties' Transactions With Securities in Exiqon A/S

VEDBAEK, Denmark, September 2 /PRNewswire-FirstCall/ -- Pursuant to section 28a of the Danish Securities Trading Act, Exiqon A/S is required to publish the managements' and their closely related parties' transactions with shares and related securities in Exiqon A/S. Name: ...

Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists

... TUSTIN, Calif., May 29 /PRNewswire/ -- exiqon Diagnostics, announced today a strategic commercia...owledge on the latest topics in cancer treatment. exiqon Diagnostics, a leader in individualizing cancer ca...ric oncology portal. MedTrust Online will add exiqon Diagnostics service offerings, extensive clinical ...

Interim Report for the Period 1 January - 30 September 2008 (Unaudited)

...EK, Denmark, November 26 /PRNewswire-FirstCall/ -- exiqon A/S, traded at the NASDAQ OMX Copenhagen ("EXQ"), ...hough the supply problems have now been addressed, exiqon revises its 2008 total year guidance of revenue of... - The integration of former Oncotech Inc - now exiqon Diagnostics Inc - remains on track for the f...

Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer

... might benefit the patient." Dr. Cynthia French, exiqon Diagnostics Chief Scientific Officer, stated, "The...ce. The latter is offered to our customers through exiqon Pharma Services." About Exiqon exiqon is a biotech company with activities in three busi...

Exiqon A/S Today Announces a Grant of License to Roche Diagnostics

...To OMX Nordic Exchange Copenhagen and the Press. exiqon A/S today announces a grant of license to Roche Di...lties on future product sales are not disclosed. exiqon retains its financial outlook for 2008 including a...of current incentive plans, including warrants.. exiqon maintains its long-term financial goal of profitab...

Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)

...ch expected break even by 2011 and on track towards our goal of a cash flow positive life sciences business by the end of 2009, there is no doubt that exiqon is in a sweet spot in the biotechnology market. We see a strong interest in miRNA and we are very excited about the launch of our first molecular diag...

Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award

...-- Frost & Sullivan has announced the selection of exiqon as the recipient of its 2008 Growth Strategy Leade...ent analysis of the molecular diagnostic market. exiqon was selected for this award because of the company...t & Sullivan viewed the acquisition of Oncotech by exiqon as both well-timed and well-executed on the heels ...

Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer

... Summary: exiqon Today Announced the Appointment of Cynthia K. Fren... /PRNewswire-FirstCall/ -- Cynthia K. French joins exiqon from Affymetrix where she served as Vice President...ncluding the CLIA laboratory. Erik Holmlin joins exiqon from BD Diagnostics, GeneOhm, where he held a numb...

Exiqon in Biological Products

miRCURY LNA Northern Blotting Detection probes from Exiqon

Description: Exiqon's miRCURY LNA technology enables sensitive and specific detection of microRNAs (miRNAs) by Northern blotting. miRCURY LNA Detection probes have high binding affinity and discrimination, enabling the specific and sensitive detection of miRNAs. Due to the high binding affinity of the miRCURY L...
Company:Exiqon

miRCURY LNA in situ Detection probes from Exiqon

Description: Exiqon's miRCURY LNA technology enables sensitive and specific detection of microRNAs (miRNAs) by in situ hybridisation. miRCURY LNA in situ detection probes have high binding affinity and discrimination, enabling the specific and sensitive detection of miRNAs. Specific in situ detection of miRNA i...
Company:Exiqon

LNA-ISH Cytogenetics - Human centromere alpha satelliteISH probes from Exiqon

Description: Exiqons LNA technology enables sensitive, fast and specific detection of chromosomal sequences directly on intact chromosomes. Short hybridisation time ( Works on fixed cells and chromosome spreads Multiplex capability Available with different tags Pre-validated probes Probes available w...
Company:Exiqon

Custom LNA Oligonucleotide synthesis from Exiqon

Description: Custom LNA Oligonucleotide synthesis High quality Custom LNA Oligonucleotides are available for a variety of different specialty applications and innovative products. Please inquire for further details....
Company:Exiqon

miRCURY LNA Array microarray slides from Exiqon

Description: miRCURY Array LNA microarray slides for microRNA expression profiling miRCURY LNA Array microarray slides incorporate Exiqons unique Locked Nucleic Acid (LNA) technology to provide unrivalled sensitivity and excellent mismatch discrimination for short microRNA (miRNA) targets. miRCURY LNA Array...
Company:Exiqon